Evidence map›Paper›PMID 42892787›Full record

ArticleOpen forum infectious diseases2026

Estimation of Antimicrobial-Resistant

Lisa E Manhart, Mary Bridget Waters, Christine M Khosropour, Kristen M Kreisel, Anika Parker, Emily D Pollock, Kevin Hybiske, Jørgen S Jensen

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lisa E ManhartDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-4896-7654
Mary Bridget WatersDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-5624-5443
Christine M KhosropourDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-9743-0829
Kristen M KreiselDivision of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-5284-9960
Anika ParkerDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
Emily D PollockPredict Division, Center for Forecasting and Analytics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-9448-9817
Kevin HybiskeDivision of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-2967-3079
Jørgen S JensenDepartment of Bacteria, Parasites, and Fungi, Research Unit for Reproductive Microbiology, Statens Serum Institut, Copenhagen, Denmark.

Funding

Cumulative burden of Chlamydia trachomatis and Mycoplasma genitalium in the US: implications for screening guidelines and antimicrobial resistanceR01AI161019 · NIAID · UNIVERSITY OF WASHINGTON · PI MANHART, LISA E · 2021 to 2025
$3.1M
NIAID NIH HHS R01 AI161019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistanceMycoplasma genitalium

Identifiers

PMID42892787
PMCPMC13675252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.